vedolizumab,ustekinumab
takeda,janssen
['vedo', 'crohn', ' vedo']
#ddw23 kayal with prop-rd data on crohn s disease on the j pouch. prospective multi center cohort, measured mpdai. lots of uste, tnf, vedo use. 57% remission at 12m. change in rx in 31%, but did not sig increase remission. we need better options for these difficult to treat pts
Physician-scientist studying inflammatory bowel disease,reproducible medical research.Chair-elect of CCF NSAC. @ibddoctor@med-mastodon.com #rstats #USMNT #Zwift